215600.KQ
SillaJen, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,410.00
−2.23%Year over year
Reported trailing growth
- Revenue
- +69.2%
- EBITDA
- -56.8%
- EBIT
- +0.9%
- EPS
- +4.6%
- Free cash flow
- +5.2%
- Operating cash flow
- -13.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +22.5%
- EBITDA
- -4.3%
- EBIT
- +4.7%
- Net income
- +9.3%
- EPS
- +20.0%
- Free cash flow
- -25.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026